Literature DB >> 15587912

[Adenocarcinoma arising from endometriosis in scar from a cesarean section treated with the use of plastic mesh].

Anita Olejek1, Wojciech Bichalski, Beata Rembielak-Stawecka, Adam Ziółkowski.   

Abstract

OBJECTIVES: Abdominal wall endometriosis is usually a secondary process in scars after a cesarean section or appendectomy. Malignant transformation is an infrequent complication of endometriosis. The great majority of cases belong to adenocarcinoma. Only 21.3% of cases of malignant transformation of endometriosis occur at extragonadal pelvic sites, 4% of cases in scars after laparotomy. STUDY
DESIGN: This is a case report of malignant transformation of endometriosis to adenocarcinoma in scar after cesarean section in 45-year old woman.
CONCLUSIONS: In cases of abdominal wall endometriosis in scars after cesarean section surgical treatment is a method of choice. Treatment consisted in wide surgical resection followed by prosthetic abdominal wall repair. Using a plastic mesh is a method of choice for abdominal wall reconstruction after surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15587912

Source DB:  PubMed          Journal:  Ginekol Pol        ISSN: 0017-0011            Impact factor:   1.232


  3 in total

1.  Therapy of a clear cell adenocarcinoma of unknown primary arising in the abdominal wall after cesarean section and after hysterectomy.

Authors:  Stefanie Aust; Denise Tiringer; Christoph Grimm; Josefine Stani; Martin Langer
Journal:  Wien Klin Wochenschr       Date:  2014-10-10       Impact factor: 1.704

2.  Outcome of a multimodal therapy of a recurrent adenocarcinoma arising from Caesarean section scar endometriosis-A case report.

Authors:  Zbigniew Drukała; Beata Ciborowska-Zielińska; Jadwiga Kubrak; Danuta Rogowska
Journal:  Rep Pract Oncol Radiother       Date:  2010-05-20

Review 3.  Endometriosis-associated malignant transformation in abdominal surgical scar: A PRISMA-compliant systematic review.

Authors:  Anca Mihailovici; Misgav Rottenstreich; Svetlana Kovel; Ilan Wassermann; Noam Smorgick; Zvi Vaknin
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.